Recurrent endometrial cancer after surgery alone: Results of salvage radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 2, 2000, Pages 405-413

  Jereczek Fossa, Barbara ^a,b   Badzio, Andrzej ^a   Jassem, Jacek ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Endometrial carcinoma; Linear quadratic model; Prognostic factors; Radiotherapy; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MODEL; MULTIMODALITY CANCER THERAPY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RELAPSE; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE;

EID: 0033824311     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00642-8     Document Type: Article

References (56)

1. Boring C.C., Squires T.S., Tong T., et al. Cancer statistics. Ca J Clin. 44:1994;7-26.
2. Elliott P., Green D., Coates A., et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer. 4:1994;84-93.
3. Nori D., Hilaris B.S., Tome M., et al. Combined surgery and radiation in endometrial carcinoma An analysis of prognostic factors . Int J Radiat Oncol Biol Phys. 13:1987;489-497.
4. Ayhan A., Tuncer Z.S., Tuncer R., et al. Risk factors for recurrence in clinically early endometrial carcinoma An analysis of 183 consecutive cases . Eur J Obstet Gynecol. 57:1994;167-170.
5. Carey M.S., O'Connel G.J., Johanson C.R., et al. Good outcome associated with standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol. 57:1995;138-144.
6. Meerwaldt J.H., Hoekstra J.M., van Putten W.L.J., et al. Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors. Int J Radiat Oncol Biol Phys. 18:1990;299-304.
7. Jereczek-Fossa B., Badzio A., Jassem J. Surgery followed by radiotherapy in endometrial cancer Analysis of survival and patterns of failure . Int J Gynecol Cancer. 9:1999;285-294.
8. Podczaski E., Kaminski P., Gurski K., et al. Detection and patterns of treatment failure in 300 consecutive cases of "early" endometrial cancer after primary surgery. Gynecol Oncol. 47:1992;323-327.
9. Jereczek-Fossa B., Jassem J., Nowak R., et al. Late complications after postoperative radiotherapy in endometrial cancer Analysis of 317 consecutive cases with application of linear-quadratic model . Int J Radiat Oncol Biol Phys. 41:1998;329-338.
10. Bliss P., Cowie V.J. Endometrial carcinoma Does the addition of intracavitary vaults caesium to external beam therapy postoperatively result in improved control or increased morbidity? Clin Oncol. 4:1992;373-376.
11. Maggino T., Romagnolo C., Zola P., et al. An analysis of approaches to the treatment of endometrial cancer in Western Europe A CTF study . Eur J Cancer. 31A:1995;1993-1997.
12. Maggino T., Romagnolo C., Landoni F., et al. An analysis of approaches to the management of endometrial cancer in North America A CTF study . Gynecol Oncol. 68:1998;274-279.
13. Creutzberg C.L., van Putten W.L.J., Koper P.C.M., et al. Postoperative radiotherapy in pT1 endometrial carcinoma Results from a prospective randomized trial in 715 patients . (Abstr) Radiother Oncol. 48:(Suppl. 1):1998;S78.
14. Roberts JA, Brunetto VL, Keys HM; et al. A phase III randomized study of surgery vs. surgery plus adjunctive radiation therapy in intermediate risk endometrial adenocarcinoma (GOG 99) (Abstr). Proc 99th Annual Meeting Soc Gynecol Oncol 1998;70.
15. Curran W.J. Jr, Whittington R., Peters A.J., et al. Vaginal recurrences of endometrial carcinoma The prognostic value of staging by a primary vaginal carcinoma system . Int J Radiat Oncol Biol Phys. 15:1988;803-808.
16. Sears J.D., Greven K.M., Hoen H.M., et al. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer. 74:1994;1303-1308.
17. Greven K., Olds W. Isolated vaginal recurrences of endometrial adenocarcinoma and their management. Cancer. 60:1987;419-421.
18. Kuten A., Grisby P.W., Perez C.A., et al. Results of radiotherapy in recurrent endometrial carcinoma A retrospective analysis of 51 patients . Int J Radiat Oncol Biol Phys. 17:1989;29-34.
19. Aalders J.G., Abelar V., Kolstad P. Recurrent adenocarcinoma of the endometrium A clinical and histopathological study of 379 patients . Gynecol Oncol. 17:1984;85-103.
20. Poulsen M.G., Roberts S.J. The salvage of the recurrent endometrial carcinoma in the vagina and pelvis. Int J Radiat Oncol Biol Phys. 15:1988;809-813.
21. Vavra N., Denison U., Kucera M., et al. Prognostic factors related to recurrent endometrial carcinoma following initial surgery. Acta Obstet Gynecol Scand. 72:1993;205-209.
22. FIGO stages 1988 revision. Gynecol Oncol. 35:1989;125-127.
23. Perez C.A., Arneson A.N., Galaktos A. Malignant tumors of the vagina. Cancer. 31:1973;36-44.
24. Hall E.J. Radiation dose-rate A factor of importance in radiobiology and radiotherapy . Br J Radiol. 45:1972;81-97.
25. Barensden G.W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys. 8:1982;1981-1997.
26. Maciejewski B., Withers H.R., Taylor J.M.G., et al. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses; acute and late effects. Int J Radiat Oncol Biol Phys. 18:1990;101-113.
27. Withers H.R., Thames H.D., Peters L.J. A new isoeffect curve for change in dose per fraction. Radiother Oncol. 1:1983;187-191.
28. Miller A.B., Hoogstraten C., Staquet M., et al. Reporting results of cancer treatment. Cancer. 47:1981;207-214.
29. Perez C.A., Brady L.W. Quantification of treatment toxicity. Perez C.A., Brady L.W. Principles and practice of radiation oncology. 1992;51-55 JB Lippincott, Philadelphia.
30. LENT SOMA Tables. Radiother Oncol. 35:1995;17-60.
31. Rubin P., Gerle R.D., Quick R.S., et al. Significance of vaginal recurrence in endometrial carcinoma. Am J Roentgen. 89:1963;91-100.
32. Berchuck A., Anspach C., Evans A.C., et al. Postsurgical surveillance of patients with FIGO stage I/II endometrial adenocarcinoma. Gynecol Oncol. 59:1995;20-24.
33. Shumsky A.G., Brasher P.M.A., Stuart G.C.E., et al. Risk-specific follow-up for endometrial carcinoma patients. Gynecol Oncol. 65:1997;379-382.
34. Burke T.W. How should we monitor women treated for endometrial carcinoma? Gynecol Oncol. 65:1997;377-378. (Editorial).
35. Impact of follow-up testing on survival and health-related quality of life in breast cancer patients A multicenter randomized control trial . J Am Med Assoc. 271:1994;1464-1467.
36. Rosselli Del Turco M., Palli D., Cariddi A., et al. Intensive diagnostic follow-up after treatment of primary breast cancer A randomized trial . J Am Med Assoc. 271:1994;1593-1597.
37. Mandell L.R., Nori D., Hilaris B. Recurrent stage I endometrial carcinoma Results of treatment and prognostic factors . Int J Radiat Oncol Biol Phys. 11:1985;1103-1109.
38. Ackerman I., Malone S., Thomas G., et al. Endometrial carcinoma Relative effectiveness of adjuvant irradiation vs therapy reserved for relapse . Gynecol Oncol. 60:1996;177-183.
39. Pirtoli L., Ciatto S., Cionini L. ; et al. Salvage with radiotherapy of postsurgical relapses of endometrial cancer. Tumori. 66:1980;475-480.
40. Phillips G.L., Prem K.A., Adcock L.L., et al. Vaginal recurrences of adenocarcinoma of the endometrium. Gynecol Oncol. 13:1982;323-328.
41. Ahmad N.R., Lanciano R.M., Corn B.W., et al. Postoperative radiation therapy for surgically staged endometrial cancer Impact of time factors (overall treatment time and surgery-to-radiation interval) on outcome . Int J Radiat Oncol Biol Phys. 33:1995;837-842.
42. Lybeert M.L., van Putten W.L.J., Ribot J.G., et al. Endometrial carcinoma High dose-rate brachytherapy combination with external irradiation. A multivariate analysis of relapses . Radiother Oncol. 16:1989;245-252.
43. Morrow C.P., Bundy B.N., Kurman R.J., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium A Gynecologic Oncology Group study . Gynecol Oncol. 40:1991;55-65.
44. Fishman D.A., Roberts K.B., Chambers J.T., et al. Radiation therapy as exclusive treatment for medically inoperable patients with stage I and II endometrioid carcinoma of the endometrium. Gynecol Oncol. 61:1996;189-196.
45. Grigsby P.W., Perez C.A., Kuten A., et al. Clinical stage I endometrial cancer Results of adjuvant irradiation and patterns of failure . Int J Radiat Oncol Biol Phys. 21:1991;379-385.
46. Bedwinek J., Galakatos A., Camel M., et al. Stage I, grade III adenocarcinoma of the endometrium treated with surgery and irradiation. Cancer. 54:1984;40-47.
47. Rantanen V., Grenman S., Kulmala J., et al. Radiation sensivity of endometrial carcinoma in vitro. Gynecol Oncol. 44:1992;217-222.
48. Perez C.A., Garipagaoglu M. Vagina. Perez C.A., Brady L.W. Principles and practice of radiation oncology. 2nd ed. 1997;1891-1910 Lippincott, Philadelphia.
49. Morris M., Alvarez R.D., Kinney W.K., et al. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol. 60:1996;288-291.
50. Brunschwig A. Surgical treatment of recurrent endometrial cancer. Obstet Gynecol. 18:1961;272-276.
51. Pierga J.-Y., Dieras V., Paraiso D., et al. Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin and 5-fluorouracil A phase II study . Gynecol Oncol. 60:1996;59-63.
52. Jeyarajah A., Gallagher C.J., Blake P.R., et al. Long-term follow-up of gonadotrophin-releasing hormone analog treatment for recurrent endometrial cancer. Gynecol Oncol. 63:1996;47-52.
53. Ball H.G., Blessing J.A., Lentz S.S., et al. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium A Gynecologic Oncology Group study . Gynecol Oncol. 62:1996;278-281.
54. Pinelli D.M., Fiorica J.V., Roberts W.S., et al. Chemotherapy plus sequential hormonal therapy for advanced and recurrent endometrial carcinoma A phase II study . Gynecol Oncol. 60:1996;462-467.
55. Reddy S., Lee M.S., Hendrickson F.R. Pattern of recurrence in endometrial carcinoma and their management. Radiol. 133:1979;737-740.
56. Corn B.W., Lanciano R.M., D'Agostino R., et al. The relationship of local and distant failure from endometrial cancer Defining a clinical paradigm . Gynecol Oncol. 66:1997;411-416.